Radoslaw Parma is an interventional cardiologist at the Medical University of Silesia and Górnośląskie Centrum Medyczne in Katowice, Poland. He specialises in TAVI, including redo-TAVI, bicuspid aortic valve interventions and CT-based procedural planning. He is Principal Investigator of the international ReTAVI Registry, a European Commission medical-device expert, Director of the THT Conference and EAPCI Congress faculty member.

Radoslaw Parma is an interventional cardiologist at the Division of Cardiology and Structural Heart Diseases, Medical University of Silesia / Górnośląskie Centrum Medyczne, Katowice, Poland, where he has practiced since 2002. He specializes in transcatheter aortic valve implantation (TAVI), with particular expertise in redo-TAVI procedures, bicuspid aortic valve interventions, and CT-based procedural planning. He is Principal Investigator of the international ReTAVI Registry (NCT05601453), a multicenter study evaluating redo-TAVI outcomes across over 60 centres. Dr. Parma served as Chair of the EAPCI Training & Certification Committee at the European Society of Cardiology (2022–2024) and is an Expert Panel Member on Medical Devices for the European Commission / European Medicines Agency. He is a co-author of multiple ESC/EAPCI consensus documents and guidelines on TAVI procedures, including expert consensus statements on bicuspid valve sizing and redo-TAVI planning with the SAPIEN platform. He directs the annual Transcatheter Heart Team (THT) Conference and serves as faculty and programme producer for EuroPCR & EAPCI Congress. He is currently pursuing an Executive MBA in Healthcare Management (SGH–WUM, Warsaw).​​​​​​​​​​​​​​​​